Abiomed Inc. buy tbackenh
Start price
21.08.21
/
60%
€299.10
Target price
21.08.22
€325.00
Performance (%)
-10.60%
End price
22.08.22
€267.40
Summary
This prediction ended on 22.08.22 with a price of €267.40. The price of Abiomed Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.60%. tbackenh has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abiomed Inc. | - | - | - |
| iShares Core DAX® | 4.094% | 3.543% | 17.404% |
| iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% |
| iShares Nikkei 225® | -1.572% | -4.633% | 15.731% |
| iShares S&P 500 | 1.822% | 0.963% | 30.396% |
According to tbackenh what are the pros and cons of Abiomed Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Future proof or reliable business model
Cons
Comments by tbackenh for this prediction
In the thread Abiomed Inc. diskutieren
Buy Abiomed Inc.
Kursziel gesetzt auf 325,0
In the thread Trading Abiomed Inc.
Die von tbackenh gewählte maximale Laufzeit wurde überschritten